1-22637683-G-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The ENST00000374642.8(C1QA):c.67G>A(p.Glu23Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00321 in 1,614,002 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. E23Q) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000374642.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
C1QA | NM_015991.4 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 | ENST00000374642.8 | NP_057075.1 | |
C1QA | NM_001347465.2 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 | NP_001334394.1 | ||
C1QA | NM_001347466.2 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 | NP_001334395.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
C1QA | ENST00000374642.8 | c.67G>A | p.Glu23Lys | missense_variant | 2/3 | 1 | NM_015991.4 | ENSP00000363773 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00320 AC: 487AN: 152146Hom.: 5 Cov.: 33
GnomAD3 exomes AF: 0.00316 AC: 794AN: 250948Hom.: 7 AF XY: 0.00313 AC XY: 425AN XY: 135676
GnomAD4 exome AF: 0.00321 AC: 4690AN: 1461738Hom.: 20 Cov.: 32 AF XY: 0.00317 AC XY: 2305AN XY: 727158
GnomAD4 genome AF: 0.00320 AC: 487AN: 152264Hom.: 5 Cov.: 33 AF XY: 0.00364 AC XY: 271AN XY: 74450
ClinVar
Submissions by phenotype
not provided Benign:3
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2023 | C1QA: BP4, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
C1Q deficiency Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center | Jul 25, 2016 | - - |
Likely benign, criteria provided, single submitter | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | Oct 09, 2014 | - - |
C1QA-related disorder Benign:1
Benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Sep 09, 2019 | This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at